Financial reports
ARS
2023 FY
Annual report to shareholders
2 Apr 24
10-K
2023 FY
Annual report
8 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
4 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Other Events
25 Apr 24
8-K
Completion of Acquisition or Disposition of Assets
3 Apr 24
8-K
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
8 Mar 24
8-K
XOMA Enters into Agreement to Acquire Kinnate Biopharma
16 Feb 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
XOMA Announces Stock Repurchase Program of up to $50 Million
2 Jan 24
8-K
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
19 Dec 23
8-K
XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value
7 Nov 23
8-K
Other Events
31 Oct 23
8-K
Termination of a Material Definitive Agreement
27 Oct 23
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
3 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
19 Mar 24
S-4
Registration of securities issued in business combination transactions
11 Mar 24
S-3
Shelf registration
8 Mar 24
SC TO-T
Third party tender offer statement
4 Mar 24
SC TO-C
Information about tender offer
27 Feb 24
S-8
Registration of securities for employees
18 May 23
S-8
Registration of securities for employees
30 Jan 23
S-8
Registration of securities for employees
26 May 22
424B5
Prospectus supplement for primary offering
5 Aug 21
Proxies
DEFA14A
Additional proxy soliciting materials
2 Apr 24
DEF 14A
Definitive proxy
2 Apr 24
DEFA14A
Additional proxy soliciting materials
4 Apr 23
DEF 14A
Definitive proxy
4 Apr 23
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEF 14A
Definitive proxy
7 Apr 22
DEFA14A
Additional proxy soliciting materials
8 Apr 21
DEF 14A
Definitive proxy
8 Apr 21
PRE 14A
Preliminary proxy
26 Mar 21
DEFA14A
Additional proxy soliciting materials
9 Apr 20
Other
CT ORDER
Confidential treatment order
18 Nov 22
CERT
Certification of approval for exchange listing
12 Apr 21
EFFECT
Notice of effectiveness
22 Mar 21
CORRESP
Correspondence with SEC
17 Mar 21
UPLOAD
Letter from SEC
17 Mar 21
CERT
Certification of approval for exchange listing
14 Dec 20
SEC STAFF
SEC staff action: Order
18 Feb 20
SEC STAFF
SEC staff action: Order
7 Feb 20
CT ORDER
Confidential treatment order
3 Feb 20
CT ORDER
Confidential treatment order
3 Feb 20